First Time Loading...
I

Immune Pharmaceuticals Inc
OTC:IMNPQ

Watchlist Manager
Immune Pharmaceuticals Inc
OTC:IMNPQ
Watchlist
Price: 0.001 USD Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

20.7m
-7%
Assets
Growth Rates:
1 Year
-7%
3 Years
-49%
5 Years
-35%
7 Years
+70%
10 Years
-
19.9m
+13%
Liabilities
Growth Rates:
1 Year
-9%
3 Years
-22%
5 Years
-18%
7 Years
-25%
10 Years
-
842k
-82%
Equity
Growth Rates:
1 Year
+47%
3 Years
-94%
5 Years
-89%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Immune Pharmaceuticals Inc

20.7m
Assets
19.9m
Liabilities
20.7m
Assets
19.9m
Liabilities
Current Assets 364k
Cash & Short-Term Investments 76k
Other Current Assets 288k
Non-Current Assets 20.4m
PP&E 97k
Intangibles 20.2m
Other Non-Current Assets 100k
Current Liabilities 14.9m
Accounts Payable 5.5m
Accrued Liabilities 1.7m
Other Current Liabilities 7.6m
Non-Current Liabilities 5m
Long-Term Debt 870k
Other Non-Current Liabilities 4.1m

Balance Sheet
Immune Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017
Assets
Cash & Cash Equivalents
1
5
2
6
0
0
7
5
0
7
Cash Equivalents
1
5
2
6
0
0
7
5
0
7
Inventory
0
1
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
1
7
3
7
0
0
7
5
1
7
PP&E Net
1
0
0
0
0
0
0
0
0
0
PP&E Gross
1
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
2
1
2
2
0
0
0
0
0
0
Intangible Assets
0
0
0
0
4
31
31
31
18
21
Other Long-Term Assets
0
0
2
1
0
0
0
0
0
0
Total Assets
2
N/A
8
+231%
5
-38%
8
+60%
4
-45%
32
+663%
38
+20%
36
-4%
19
-47%
29
+50%
Liabilities
Accounts Payable
3
2
1
1
2
5
1
2
4
4
Accrued Liabilities
3
2
2
2
1
4
4
2
2
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
1
1
8
0
2
2
1
3
3
Other Current Liabilities
0
0
1
1
1
1
0
0
1
0
Total Current Liabilities
10
5
5
12
3
11
7
6
9
9
Long-Term Debt
0
1
0
0
0
3
2
3
1
1
Deferred Income Tax
0
0
0
0
0
11
11
11
6
4
Other Liabilities
10
10
14
12
0
1
0
7
0
0
Total Liabilities
20
N/A
17
-17%
19
+13%
25
+31%
4
-83%
26
+532%
20
-22%
27
+31%
17
-38%
15
-10%
Equity
Common Stock
0
0
0
0
0
0
1
2
0
0
Retained Earnings
196
235
251
266
16
22
46
63
96
114
Additional Paid In Capital
180
228
238
250
15
28
63
71
98
127
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
2
2
1
1
0
0
0
0
0
0
Total Equity
18
N/A
9
+49%
14
-56%
17
-21%
0
N/A
5
+39 064%
18
+220%
10
-46%
3
-74%
14
+447%
Total Liabilities & Equity
2
N/A
8
+231%
5
-38%
8
+60%
4
-45%
32
+663%
38
+20%
36
-4%
19
-47%
29
+50%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
1
1
2
8
21
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Summary
IMNPQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMNPQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMNPQ stock valuation using valuation multiples.
Wall Street Estimates
IMNPQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMNPQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.